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Abstract: An eco-benign approach towards the synthesis of 1,2,4-triazolinones incorporated with isoindoline-1,3-
dione  (4a-j)  and  9H-fluoren-9-imine  (5a-j)  was  carried  out  using  sydnones  (1a-j)  as  synthon  under  magnesium 
perchlorate as catalyst. The newly synthesized compounds were screened for anti-tubercular activities. 
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1. Introduction    
Sydnones  are  the  most  widely  studied  members  of  the  group  of  heterocycles  viz.  mesoionic 
compounds as these compounds act as useful and novel precursors for synthesis of various biologically 
active  heterocycles  such  as  pyrazoles,
11,3,4-oxadiazoles,
2  phenyl  indazoles,
3  pyrazolines and tetrazines
4 
through  1,3-dipolar  cycloaddition  and  addition-elimination  reactions.  As  of  this  criterion,  we  were 
prompted to work on the ring transformation reactions of sydnone into 1,3,4-oxadiazole which was further 
converted to 1,2,4-triazolinones incorporated with isoindoline-1,3-dione and 9H-fluoren-9-imine.  
Tuberculosis  (TB),  a  contagious  disease  caused  by  Mycobacterium  tuberculosis  (MTB),  still 
remains a major public health threat worldwide despite ready availability of effective treatment as these 
pathogens are getting resistance against anti-mycobacterial agents.
5-7 The WHO has estimated that about 
eight million new cases of tuberculosis occur per annum and up to three million individuals die due to this 
disease
8 and if this ravage of tuberculosis is left unchecked, there will be about 1 billion more people newly 
infected with TB till 2020.
9  
   Some  substituted  isoindoline-1,3-dione  derivatives  appeared  to  function  as  pharmacophoric 
chromophore  having  diverse  biological  activities  such  as  tumor  necrosis  factor-α  (TNF-α)  regulating 
activity,
10  hypoglcemic,
11  antiviral,
12  antiandrogenic,
13  antiangiogenic,
14  antiinflammatory,
15  herbicidal,
16 
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anticonvulsant,
17  hypolipidimic,
18  and  antitumour
19.  Thalidomide,  (RS)-2-(2,6-dioxopiperidin-3-yl)-1H-
isoindole-1,3(2H)-dione (1) drug comprises of N-substituted isoindoline-1,3-dione derivative which acts as 
antineoplastic agent
20. Fluorenone derivatives are associated with DNA intercalation property
21 that has 
been  designed  as  potential  immunomodulatory,  cytotoxic  and  chemotherapeutic  agents.
22  Tilorone 
hydrochloride, 2,7-Bis[2-(diethylamino)ethoxy]fluoren-9-one dihydrochloride (2) is a low molecular weight 
antiviral drug contains fluorenone chromophore, which is effective in vivo against several DNA and RNA 
viruses.
23  
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Figure 1.  Pharmacologically active isoindolin-1,3(2H)-dione and fluorenone  compounds 
The demand for green synthesis in organic transformations is increasing popularly day by day. 
Hence,  in  the  present  work,  we  made  an  attempt  for  the  eco-benign  synthesis  of  1,2,4-triazolinones 
incorporated  with  phthalimide  and  fluorenone  functions  using  magnesium  perchlorate  as  Lewis  acid 
catalyst that can interact with the lone pair of electrons present in the functional group required for the 
synthesis  of  title  compounds  through  ring  insertion  reaction.  The  newly  synthesized  compounds  were 
characterized by FTIR, 
1H NMR, MS and elemental analyses. Further, the title compounds were analyzed 
for their antitubercular assay.  
 
2. Results and Discussion 
2.1 Chemistry 
Initially, the preparation of title compounds (4a-j and 5a-j) was attempted in absence of catalyst, 
but the yield was found to be poor and took prolonged time (8-10 h) for completion of the reaction. The 
nucleophilic attack by the amine on the carbonyl carbon in the first step is reversible and the rate of 
formation of product solely depends on removal of water molecule in final step which may be removed 
under azeotropic distillation, using molecular sieves or dehydrating agents such as tetramethyl orthosilicate 
and trimethyl orthoformate. But these methods required high reaction temperatures, prolonged time and use 
of costly reagents.
24 Hence, we underwent to carry out the same reaction in presence of different Lewis acid 
catalysts viz. ZnCl2, AlCl3, FeCl3, MgBr2, CuSO4.5H2O and Mg(ClO4)2 as these can be easily removed from 
the  reaction  mixture.  The  yield  of  the  product  (4a-j)  using  these  different  catalysts  was  found  to  be 
improved and the range of yield observed was 60-65%, 59-61%, 56-58%, 45-50%, 65-68%, 48-51% and 
76-82% respectively. As per the earlier reported methods, synthesis of Schiff bases involved the use of few 
drops of acids viz. sulphuric acid
25 or glacial acetic acid
26 to initiate the reaction, but they proved to give 
lower yields. We made an effort in replacing these acids by Lewis acid catalysts mentioned above and 
found advantage in respect to mild reaction condition and better yields for the incorporation of 4-amino-
1,2,4-triazolinone with flourenone (5a-j) using Mg(ClO4)2. The use of Lewis acid catalyst involves the Atukuri et al., Org. Commun. (2011) 4:4 94-104 
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formation of “tight ion pair complex” between empty d-orbitals of transition metal present in the catalyst 
and non-bonded electrons of carbonyl oxygen which makes the carbonyl carbon more electrophilic towards 
nucleophilic attack. As a result, the attack of lone pairs of electrons on nitrogen atom of 4-amino-1,2,4-
triazolinone  (3a-j)  to  carbonyl  carbon  of  both  phthalic  anhydride  and  fluorenone  (Scheme  2  and  3) 
derivatives was observed with excellent yields (76-82%) within 3-4 hrs with excellent yields. Among all the 
Lewis acid catalysts we used, Mg(ClO4)2 catalyzed reaction was found to commence with excellent yields 
and is considered to be an excellent Lewis acid catalyst for the condensation of less electrophilic carbonyl 
compounds with poorly nucleophilic amines to afford N-substituted phthalimide (4a-j) and imine (5a-j) 
derivatives from 4-amino-1,2,4-triazolinones (3a-j). To our satisfaction we found the use of 0.0005mol of 
Mg(ClO4)2 resulted in quantitative formation of corresponding products. But we failed to get azetidinone 
derivatives when Schiff bases (5a-j) were treated with chloroacetyl chloride.  
The spectra of title compounds (4a-j and 5a-j) were in good agreement with the assigned structures. 
The IR spectra of isoindoline-1,3-diones revealed a sharp band for carbonyl group of 1,2,4-triazolinone ring 
around 1713-1727 cm
-1. The carbonyl stretching of phthalimide was observed around 1724-1766 cm
-1. The 
C=N band was observed around 1611-1628 cm
-1. In case of 
1H NMR, a singlet around δ 2.17-2.22 ppm 
(3H) was attributed to p-tolyl methyl protons (4b, 4f, 5b, 5f). In all the compounds a singlet in the region δ 
2.42-2.56 ppm (3H) was assigned for the C5 methyl protons of 1,2,4-triazolinone ring. A singlet around δ 
3.59-3.68  ppm  (3H)  was  assigned  for  methoxy  protons  (4d,  4h,  5d,  5h).  The  aromatic  protons  were 
resonated as muliplet around δ 7.08-8.91 ppm. 
 
2.2 Antitubercular assay 
All the title compounds prepared have been successfully screened for their potential biological 
activities against standard strain of Mycobacterium tuberculosis H37 RV (ATCC-27294) by Alamar blue 
assay method. In case of isoindoline-1,3-diones (4a-j), the halogen substituted (4c, 4e, 4g) and 4a, 4b, 4f 
derivatives have shown very good activity. The nitro substituted compounds (4i, 4j) have shown moderate 
activity, whereas methoxy substituted compounds (4d, 4h) have shown least activity. However, the fluoren-
9-imine derivatives (5a-j) did not show any considerable activity (Table 1).  
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Scheme 1. Synthetic route of title compounds 4a-j and 5a-j 
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Scheme 2. Proposed mechanism for the formation of compound 4a-j 
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Scheme 3. Proposed mechanism for the formation of compound 5a-j Atukuri et al., Org. Commun. (2011) 4:4 94-104 
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Table 1. Antitubercular activity of synthesized compounds (4a-j and 5a-j)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All compounds were tested at 5, 10, 15, 20, 25, 30 µg/mL concentrations by serial dilution.   
 
3. Conclusion 
From the present work, it can be concluded that the methodology followed provides simple, mild 
and facile route for the condensation of 4-amino-1,2,4-triazolinones (3a-j) with phthalic anhydride and 
fluorenone functions to yield N-substituted phthalimide (4a-j) and fluoren-9-imine (5a-j) derivatives using 
magnesium perchlorate as catalyst with excellent yields. The formed bisheterocycles were found to exhibit 
good antitubercular activities. 
 
 
 
 
Compound  R  MIC (µg/mL) 
 4a  C6H5  06.6 
 4b  p- CH3C6H4  07.3 
4c  p-ClC6H4  05.7 
4d  p-OCH3C6H4  21.0 
4e  p-BrC6H4  05.3 
4f  m- CH3C6H4  07.2 
4g  m-ClC6H4  05.2 
4h  m-OCH3C6H4  23.0 
4i  p-NO2C6H4  15.0 
4j  m-NO2C6H4  18.0 
5a  C6H5  10.7 
 5b  p-CH3C6H4  08.2 
5c  p-ClC6H4  08.8 
5d  p-OCH3C6H4  25.0 
5e  p-BrC6H4  09.9 
5f  m- CH3C6H4  08.2 
5g  m-ClC6H4  11.6 
5h  m-OCH3C6H4  28.0 
5i  p-NO2C6H4  21.0 
5j  m-NO2C6H4  25.0 
Standard  Streptomycin  06.5 Mg(ClO4)2 Catalyzed Eco-benign synthesis of 1,2,4-triazolinone derivatives 
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4. Experimental  
 
4.1 Methods and materials 
 
Melting points were determined in open capillaries. FTIR spectra (KBr) were recorded on Nicolet 
Impact-410  FT-IR  spectrometer. 
1H  NMR  spectra  were  recorded  on  Bruker-300  MHz  FT-NMR 
spectrometer with TMS as an internal standard. Mass spectra were recorded using Finnegan MAT (Model 
MAT 8200) spectrometer and elemental analyses were carried out using Heraus CHN rapid analyzer. Purity 
of the compounds was monitored by TLC on silica gel plate using n-hexane and ethyl acetate as eluent. 4-
Amino-2-aryl-5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one (3a-j) were prepared from 3-arylsydnones (1a-
j) according to the reported method via 5-methyl-3-aryl-oxadizolin-2-one (2a-j).
 2, 27-28 
 
 
4.1.1. Procedure for the preparation of isoindoline-1,3-diones (4):  
 
4-Amino-2-aryl-5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one  (0.001mol),  phthalic  anhydride 
(0.001 mol) and magnesium perchlorate (0.0005 mol) were taken in dry butanol (20 mL) and refluxed for 5 
h. Completion of the reaction was monitored by TLC using hexane and ethyl acetate (7:3) as eluent. After 
completion of reaction, the reaction mixture was poured into water and partitioned between water and 
dichloromethane. The organic layer was washed with brine solution, dried over anhydrous sodium sulphate 
and solvent was evaporated to dryness to get solid compound 4a-j.  
 
 
2-(3-Methyl-5-oxo-1-phenyl-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4a).  Yield  85%;  M.W. 
320.3; m.p. 114-116 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.52 (s, 3H, C5-CH3), 7.19-8.02 (m, 9H, Ar-
H); IR (KBr) cm
-1: 1762, 1724 (C=O, phth), 1717 (C=O), 1605 (C=N); MS m/z: 320 (M
+, 35), 306 (20), 
278 (20), 250 (15), 235 (10), 207 (15), 179 (25), 165 (20), 158 (30), 149 (45), 130 (40), 118 (15), 105 (80), 
91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for C17H12N4O3: C, 63.75%; H, 3.78%; N, 17.49%. Found: 
C, 63.72%; H, 3.77%; N, 17.50%. 
 
2-(3-Methyl-5-oxo-1-p-tolyl-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4b).  Yield  79%;  M.W. 
334.33; m.p. 123-125 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.17 (s, 3H, Ar-CH3), 2.45 (s, 3H, C5-
CH3), 7.22-8.11 (m, 8H, Ar-H); IR (KBr) cm
-1: 1758, 1725 (C=O, phth), 1719 (C=O), 1615 (C=N); MS 
m/z: 334 (M
+, 20), 320 (25), 292 (20), 264 (15), 250 (15), 235 (10), 207 (15), 179 (25), 165 (20), 158 (30), 
149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for C18H14N4O3: C, 
64.66%; H, 4.22%; N, 16.76%. Found: C, 64.67%; H, 4.23%; N, 16.74%. 
 
2-(1-(p-Chlorophenyl)-3-methyl-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione (4c). Yield 76%; 
M.W. 354.75; m.p. 106-108 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.53 (s, 3H, C5-CH3), 7.22-8.23 (m, 
8H, Ar-H); IR (KBr) cm
-1: 1759, 1732 (C=O, phth), 1723 (C=O), 1615 (C=N); MS m/z: 356 (M+2)
+, 30), 
354 (M
+, 10), 328 (20), 326 (10), 314 (20), 312 (10), 286 (30), 250 (15), 235 (10), 207 (15), 179 (25), 165 
(20), 158 (30), 149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for  
C17H11ClN4O3: C, 57.56%; H, 3.13%; N, 15.79%. Found: C, 57.55%; H, 3.12%; N, 15.77%. 
2-(1-(p-Methoxyphenyl)-3-methyl-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4d).  Yield 
78%; M.W. 350.33; m.p. 107-109 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.51 (s, 3H, C5-CH3), 3.65 (s, 
3H, OCH3), 7.31-8.15 (m, 8H, Ar-H); IR (KBr) cm
-1: 1760, 1732 (C=O, phth), 1713 (C=O), 1616 (C=N); 
MS m/z: 350 (M
+, 10), 336 (10), 308 (25), 280 (15), 252 (20), 237 (25), 207 (15), 179 (25), 165 (20), 158 
(30), 149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for C18H14N4O4: 
C, 61.71%; H, 4.03%; N, 15.99%. Found: C, 61.72%; H, 4.05%; N, 15.98%. Atukuri et al., Org. Commun. (2011) 4:4 94-104 
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2-(1-(p-Bromophenyl)-3-methyl-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione (4e). Yield 76%; 
M.W. 399.2; m.p. 135-137 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.47 (s, 3H, C5-CH3), 7.26-8.29 (m, 
8H, Ar-H); IR (KBr) cm
-1: 1763, 1728 (C=O, phth), 1718 (C=O), 1618 (C=N); MS m/z: 401 (M+2)
+, 20), 
399 (M
+, 20), 373 (10), 371 (10), 343 (25), 341 (25), 263 (35), 249 (30), 234 (25), 207 (15), 179 (25), 165 
(20), 158 (30), 149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for  
C17H11BrN4O3: C, 51.15%; H, 2.78%; N, 14.03%. Found: C, 51.17%; H, 2.79%; N, 14.01%. 
 
2-(3-Methyl-5-oxo-1-m-tolyl-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4f).  Yield  83%;  M.W. 
334.33; m.p. 118-120 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.18 (s, 3H, Ar-CH3), 2.52 (s, 3H, C5-
CH3), 7.09-8.18 (m, 8H, Ar-H); IR (KBr) cm
-1: 1758, 1724 (C=O, phth), 1721 (C=O), 1617 (C=N); MS 
m/z: 334 (M
+, 20), 320 (25), 292 (20), 264 (15), 250 (15), 235 (10), 207 (15), 179 (25), 165 (20), 158 (30), 
149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for C18H14N4O3: C, 
64.66%; H, 4.22%; N, 16.76%. Found: C, 64.64%; H, 4.22%; N, 16.74%. 
 
2-(1-(m-Chlorophenyl)-3-methyl-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4g).  Yield 
78%; M.W. 354.75; m.p. 104-106 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.45 (s, 3H, C5-CH3), 7.08-
8.33 (m, 8H, Ar-H); IR (KBr) cm
-1: 1761, 1732 (C=O, phth), 1721 (C=O), 1614 (C=N); MS m/z: 356 
(M+2)
+, 45), 354 (M
+, 15), 328 (20), 326 (10), 314 (20), 312 (10), 286 (30), 250 (15), 235 (10), 207 (15), 
179 (25), 165 (20), 158 (30), 149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. 
Calcd. for C17H11ClN4O3: C, 57.56%; H, 3.13%; N, 15.79%. Found: C, 57.57%; H, 3.14%; N, 15.77%. 
 
2-(1-(m-Methoxyphenyl)-3-methyl-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4h).  Yield 
81%; M.W. 350.33; m.p. 125-127 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.51(s, 3H, C5-CH3), 3.59 (s, 
3H, OCH3), 7.23-8.25 (m, 8H, Ar-H); IR (KBr) cm
-1: 1752, 1726 (C=O, phth), 1718 (C=O), 1611 (C=N); 
MS m/z: 350 (M
+, 10), 336 (10), 308 (25), 280 (15), 252 (20), 237 (25), 207 (15), 179 (25), 165 (20), 158 
(30), 149 (45), 130 (40), 118 (15), 105 (80), 91 (100), 77 (30), 65 (50), 40 (5). Anal. Calcd. for C18H14N4O4: 
C, 61.71%; H, 4.03%; N, 15.99%. Found: C, 61.72%; H, 4.02%; N, 15.97%. 
 
2-(3-Methyl-1-(p-nitrophenyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4i).  Yield  75%; 
M.W. 365.3; m.p. 142-144 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.50 (s, 3H, C5-CH3), 7.53-8.91 (m, 
8H, Ar-H); IR (KBr) cm
-1: 1766, 1726 (C=O, phth), 1721 (C=O), 1628 (C=N), 1560 (NO2, asym.), 1353 
(NO2, sym.); MS m/z: 365 (M
+, 15), 351 (10), 323 (25), 295 (10), 281 (25), 267 (30), 252 (15), 237 (10), 
211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 
(10). Anal. Calcd. for C17H11N5O5: C, 55.89%; H, 3.04%; N, 19.17%. Found: C, 55.88%; H, 3.02%; N, 
19.19%. 
 
2-(3-Methyl-1-(m-nitrophenyl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)isoindoline-1,3-dione  (4j).  Yield  84%; 
M.W. 365.3; m.p. 136-138 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.48 (s, 3H, C5-CH3), 7.47-8.87 (m, 
8H, Ar-H); IR (KBr) cm
-1: 1759, 1725 (C=O, phth), 1720 (C=O), 1627 (C=N), 1563 (NO2, asym.), 1353 
(NO2, sym.); MS m/z: 365 (M
+, 15), 351 (10), 323 (25), 295 (10), 281 (25), 267 (30), 252 (15), 237 (10), 
211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 
(10). Anal. Calcd. for C17H11N5O5: C, 55.89%; H, 3.04%; N, 19.17%. Found: C, 55.90%; H, 3.02%; N, 
19.15%. 
 
 
4.1.2. Method 1: Procedure for preparation of fluoren-9-imine derivatives using acid (5):  
 
4-Amino-2-aryl-5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one  (0.001mol)  and  fluorenone 
(0.001mol) were taken in dry ethanol (15mL). Glacial acetic acid (2-3 drops) was added and refluxed for 8-
10 h. Completion of reaction was monitored by TLC using hexane and ethyl acetate (8:2) as eluent. After Mg(ClO4)2 Catalyzed Eco-benign synthesis of 1,2,4-triazolinone derivatives 
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completion of reaction, the reaction mixture was cooled, concentrated and poured to ice cold water to get 
crude product which is recrystalized from petroleum ether to get yellow needles. Yield observed was 55-
58% for all the compounds (5a-j). 
 
4.1.3. Method 2: Procedure for the preparation of fluoren-9-imine derivatives using catalyst (5):  
 
4-Amino-2-aryl-5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one  (0.001mol),  fluorenone  (0.001mol) 
and magnesium perchlorate (0.0005mol) were taken in dichloromethane (20 mL) and refluxed for 3h at 60-
70 °C on water bath. Completion of reaction was monitored by TLC using hexane and ethyl acetate (8:2) as 
eluent. After completion of reaction, the contents were poured to water and partitioned between water and 
dichloromethane. The organic layer was washed with brine solution, dried over anhydrous sodium sulphate 
and solvent was evaporated to dryness to get analytical pure compound. Yield found to be 75-83% for all 
the compounds (5a-j). 
 
 
4-(9H-Fluoren-9-ylideneamino)-5-methyl-2-phenyl-2H-1,2,4-triazol-3(4H)-one (5a). Yield 82%; M.W. 
352.39; m.p. 125-127 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.47 (s, 3H, C5-CH3), 7.28-7.87 (m, 13H, 
Ar-H); IR (KBr) cm
-1: 1714 (C=O), 1611 (C=N); MS m/z: 352 (M
+, 35), 337 (30), 322 (15), 305 (20), 291 
(25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 
(40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. for C22H16N4O: C, 74.98%; H, 4.58%; N, 15.90%. 
Found: C, 74.97%; H, 4.43%; N, 15.89%. 
 
4-(9H-Fluoren-9-ylideneamino)-5-methyl-2-p-tolyl-2H-1,2,4-triazol-3(4H)-one  (5b).Yield  78%;  M.W. 
366.42; m.p. 58-60 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.19 (s, 3H, Ar-CH3), 2.49 (s, 3H, C5-CH3), 
7.26-7.67 (m, 12H, Ar-H); IR (KBr) cm
-1: 1718 (C=O), 1623 (C=N); MS m/z: 366 (M
+, 40), 351 (35), 337 
(30), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 183 (35), 180 (45), 163 
(50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. for C23H18N4O: C, 
75.39%; H, 4.95%; N, 15.29%. Found: C, 75.37%; H, 4.96%; N, 15.30%. 
 
4-(9H-Fluoren-9-ylideneamino)-2-(p-chlorophenyl)-5-methyl-2H-1,2,4-triazol-3(4H)-one  (5c).  Yield 
79%; M.W. 386.83; m.p. 102-104 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.56 (s, 3H, C5-CH3), 7.27-
8.23 (m, 12H, Ar-H); IR (KBr) cm
-1: 1721 (C=O), 1623 (C=N); MS m/z: 388 (M+2)
+, 30), 386 (M
+, 10), 
373 (25), 371 (8), 336 (30), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 
183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. 
for C22H15N4ClO: C, 68.31%; H, 3.91%; N, 14.48%. Found: C, 68.30%; H, 3.92%; N, 14.47%. 
 
4-(9H-Fluoren-9-ylideneamino)-2-(p-methoxyphenyl)-5-methyl-2H-1,2,4-triazol-3(4H)-one  (5d).Yield 
83%; M.W. 382.41; m.p. 114-116 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.42 (s, 3H, C5-CH3), 3.64 (s, 
3H, OCH3), 7.21-7.79 (m, 12H, Ar-H); IR (KBr) cm
-1: 1710 (C=O), 1613 (C=N), 1148 (C-O); MS m/z: 382 
(M
+, 25), 367 (30), 353 (35), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 
183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. 
for C23H18N4O2: C, 72.24%; H, 4.74%; N, 14.65%. Found: C, 72.22%; H, 4.74%; N, 14.66%. 
 
4-(9H-Fluoren-9-ylideneamino)-2-(p-bromophenyl)-5-methyl-2H-1,2,4-triazol-3(4H)-one  (5e).  Yield 
76%; M.W. 431.28; m.p. 134-136 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.55 (s, 3H, C5-CH3), 7.35-
8.27 (m, 12H, Ar-H); IR (KBr) cm
-1: 1723 (C=O), 1626 (C=N); MS m/z: 433 (M+2)
+, 40), 431 (M
+, 38), 
418 (30), 416 (28), 336 (30), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 
183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. 
for C22H15N4BrO: C, 61.27%; H, 3.51%; N, 12.99%. Found: C, 61.28%; H, 3.52%; N, 12.97%. 
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4-(9H-Fluoren-9-ylideneamino)-5-methyl-2-m-tolyl-2H-1,2,4-triazol-3(4H)-one (5f). Yield 75%; M.W. 
366.42; m.p. 136-138 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.22 (s, 3H, Ar-CH3), 2.46 (s, 3H, C5-
CH3), 7.26-7.89 (m, 12H, Ar-H); IR (KBr) cm
-1: 1713 (C=O), 1613 (C=N); MS m/z: 366 (M
+, 35), 351 
(25), 337 (30), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 183 (35), 180 
(45),  163  (50),  151  (55),  125  (35),  105  (40),  85  (60),  57  (80),  44  (100),  40  (10).  Anal.  Calcd.  for 
C23H18N4O: C, 75.39%; H, 4.95%; N, 15.29%. Found: C, 75.38%; H, 4.96%; N, 15.27%. 
 
4-(9H-Fluoren-9-ylideneamino)-2-(m-chlorophenyl)-5-methyl-2H-1,2,4-triazol-3(4H)-one  (5g).  Yield 
79%; M.W. 386.83; m.p. 112-114 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.58 (s, 3H, C5-CH3), 7.26-
8.27 (m, 12H, Ar-H); IR (KBr) cm
-1: 1721 (C=O), 1623 (C=N); MS m/z: 389 (M+2)
+, 40), 387 (M
+, 14), 
359 (35), 357 (17), 345 (25), 343 (12), 330 (20), 328 (10), 337 (30), 293 (25), 278 (15), 251 (15), 237 (10), 
211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 
(10). Anal. Calcd. for C22H15N4ClO: C, 68.31%; H, 3.91%; N, 14.48%. Found: C, 68.33%; H, 3.92%; N, 
14.45%. 
 
4-(9H-Fluoren-9-ylideneamino)-2-(m-methoxyphenyl)-5-methyl-2H-1,2,4-triazol-3(4H)-one (5h). Yield 
83%; M.W. 382.41; m.p. 121-123 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.45 (s, 3H, C5-CH3), 3.68 (s, 
3H, OCH3), 7.32-7.81 (m, 12H, Ar-H); IR (KBr) cm
-1: 1709 (C=O), 1620 (C=N), 1150 (C-O); MS m/z: 382 
(M
+, 25), 354 (20), 340 (20), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 211 (25), 198 (30), 
183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 (10). Anal. Calcd. 
for C23H18N4O2: C, 72.24%; H, 4.74%; N, 14.65%. Found: C, 72.26%; H, 4.75%; N, 14.65%. 
 
4-(9H-Fluoren-9-ylideneamino)-5-methyl-2-(p-nitrophenyl)-2H-1,2,4-triazol-3(4H)-one  (5i).  Yield 
75%; M.W. 397.39; m.p. 128-130 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.51 (s, 3H, C5-CH3), 7.35-
8.89 (m, 12H, Ar-H); IR (KBr) cm
-1: 1724 (C=O), 1628 (C=N), 1565 (NO2, asym.), 1355 (NO2, sym.); MS 
m/z: 397 (M
+, 25), 369 (15), 354 (30), 340 (10), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 
211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 
(10). Anal. Calcd. for C22H15N5O3: C, 66.49%; H, 3.80%; N, 17.62%. Found: C, 66.48%; H, 3.81%; N, 
17.60%. 
 
4-(9H-Fluoren-9-ylideneamino)-5-methyl-2-(m-nitrophenyl)-2H-1,2,4-triazol-3(4H)-one  (5j).  Yield 
81%; M.W. 397.39; m.p. 143-145 °C; 
1H NMR (300 MHz, CDCl3) (δ/ppm): 2.53 (s, 3H, C5-CH3), 7.27-
8.10 (m, 12H, Ar-H); IR (KBr) cm
-1: 1727 (C=O), 1619 (C=N), 1561 (NO2, asym.), 1351 (NO2, sym.); MS 
m/z: 397 (M
+, 25), 369 (15), 354 (30), 340 (10), 322 (15), 305 (20), 291 (25), 278 (15), 251 (15), 237 (10), 
211 (25), 198 (30), 183 (35), 180 (45), 163 (50), 151 (55), 125 (35), 105 (40), 85 (60), 57 (80), 44 (100), 40 
(10). Anal. Calcd. for C22H15N5O3: C, 66.49%; H, 3.80%; N, 17.62%. Found: C, 66.50%; H, 3.81%; N, 
17.61%. 
 
 
4.2 Antitubercular assay 
The  anti-tubercular  activity  of  the  test  compounds  were  evaluated  against  standard  strain  of 
Mycobacterium tuberculosis H37Rv (ATCC-27294) in BACTEC 12B medium using the microplate Alamar 
blue  assay  (MABA).
29-30Antibiotic  standard  used  was  streptomycin  at  6.5  µg/mL  concentration.  The 
compounds were tested at 5, 10, 15, 20, 25, 30 µg/mL concentrations by serial dilution against the M. 
tuberculosis H37Rv to determine minimum inhibition concentration (MIC) using MABA. 
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